Literature DB >> 18830622

Investigating differentiation mechanisms of the constituent cells of sex cord-stromal tumours of the ovary.

Panagiotis Papanastasopoulos1, Maria Repanti, Vasileia Damaskou, Vasiliki Bravou, Helen Papadaki.   

Abstract

SOX-9, an essential factor for male sexual development, can be induced by prostaglandin D2 in a Sry-independent mechanism. Recent data suggest that the hedgehog pathway is involved in the differentiation of normal Sertoli and Leydig cells. The purpose of our study was to investigate the mechanisms involved in the differentiation of ovarian sex cord-stromal tumour (SCST) cells. Two Sertoli-Leydig cell tumours and two granulosa cell tumours with a minor Sertoli element were studied using immunohistochemistry on paraffin-embedded tissue sections. Sertoli cells expressed anti-Mullerian hormone (AMH), SOX-9, prostaglandin D synthase (Pgds) and bcl-2 (in four of four cases); sonic hedgehog (Shh) and p53 (in three of four cases) and androgen receptors (AR; in one of four cases). Ki-67 index ranged from 10% to 50%. Leydig cells expressed Shh and AR (two of two cases), while they showed no expression of p53, bcl-2 and 0% Ki-67 index. Granulosa cells expressed AMH, Pgds, Shh, estrogen receptors, progesterone receptors, AR and bcl-2 (in two of two cases) and p53 (in one of two cases). Ki-67 index was 10% and 40%, respectively. Further investigation is required to clarify the role of the molecules outlined above in the histogenesis of ovarian SCST, as Pgds-mediated SOX-9 upregulation could provide a reasonable explanation for the presence of testicular differentiation in ovarian SCST.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18830622     DOI: 10.1007/s00428-008-0677-7

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  20 in total

1.  Ovarian Sertoli-Leydig cell tumor of intermediate differentiation with immature skeletal muscle heterologous elements.

Authors:  Evanthia Kostopoulou; Alexander Talerman
Journal:  Acta Obstet Gynecol Scand       Date:  2003-02       Impact factor: 3.636

2.  Evidence that Leydig cells in Sertoli-Leydig cell tumors have a reactive rather than a neoplastic profile.

Authors:  E E Mooney; Y G Man; G L Bratthauer; F A Tavassoli
Journal:  Cancer       Date:  1999-12-01       Impact factor: 6.860

3.  Ovarian Sertoli-Leydig cell tumor: a SRY gene-independent pathway of pseudomale gonadal differentiation.

Authors:  A Hittmair; B G Zelger; P Obrist; S Dirnhofer
Journal:  Hum Pathol       Date:  1997-10       Impact factor: 3.466

4.  Sox9 induces testis development in XX transgenic mice.

Authors:  V P Vidal; M C Chaboissier; D G de Rooij; A Schedl
Journal:  Nat Genet       Date:  2001-07       Impact factor: 38.330

5.  Sertoli cell differentiation is induced both cell-autonomously and through prostaglandin signaling during mammalian sex determination.

Authors:  Dagmar Wilhelm; Fred Martinson; Stephen Bradford; Megan J Wilson; Alexander N Combes; Annemiek Beverdam; Josephine Bowles; Hirofumi Mizusaki; Peter Koopman
Journal:  Dev Biol       Date:  2005-09-26       Impact factor: 3.582

6.  Recurrent juvenile granulosa cell tumor of the ovary managed by palliative radiotherapy.

Authors:  M Hirakawa; Y Nagai; C Yagi; T Nashiro; M Inamine; Y Aoki
Journal:  Int J Gynecol Cancer       Date:  2007-11-20       Impact factor: 3.437

7.  Direct interaction of SRY-related protein SOX9 and steroidogenic factor 1 regulates transcription of the human anti-Müllerian hormone gene.

Authors:  P De Santa Barbara; N Bonneaud; B Boizet; M Desclozeaux; B Moniot; P Sudbeck; G Scherer; F Poulat; P Berta
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

8.  Expression and biological role of the prostaglandin D synthase/SOX9 pathway in human ovarian cancer cells.

Authors:  Safia Malki; Frédéric Bibeau; Cécile Notarnicola; Sylvie Roques; Philippe Berta; Francis Poulat; Brigitte Boizet-Bonhoure
Journal:  Cancer Lett       Date:  2007-05-29       Impact factor: 8.679

9.  Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment.

Authors:  Christien Weenen; Joop S E Laven; Anne R M Von Bergh; Mark Cranfield; Nigel P Groome; Jenny A Visser; Piet Kramer; Bart C J M Fauser; Axel P N Themmen
Journal:  Mol Hum Reprod       Date:  2004-02       Impact factor: 4.025

10.  SOX9 is up-regulated by the transient expression of SRY specifically in Sertoli cell precursors.

Authors:  Ryohei Sekido; Isabelle Bar; Véronica Narváez; Graeme Penny; Robin Lovell-Badge
Journal:  Dev Biol       Date:  2004-10-15       Impact factor: 3.582

View more
  4 in total

1.  Immunologic adverse reaction associated with low-carbide metal-on-metal bearings in total hip arthroplasty.

Authors:  Panagiotis Aroukatos; Maria Repanti; Thomas Repantis; Vassiliki Bravou; Panagiotis Korovessis
Journal:  Clin Orthop Relat Res       Date:  2009-12-18       Impact factor: 4.176

2.  The role of beta-catenin mutation and SOX9 expression in sex cord-stromal tumours of the testis.

Authors:  F Bremmer; C L Behnes; H U Schildhaus; N T Gaisa; H Reis; H Jarry; H J Radzun; P Stroebel; S Schweyer
Journal:  Virchows Arch       Date:  2017-02-16       Impact factor: 4.064

3.  The oncogenic roles of DICER1 RNase IIIb domain mutations in ovarian Sertoli-Leydig cell tumors.

Authors:  Yemin Wang; Jiamin Chen; Winnie Yang; Fan Mo; Janine Senz; Damian Yap; Michael S Anglesio; Blake Gilks; Gregg B Morin; David G Huntsman
Journal:  Neoplasia       Date:  2015-08       Impact factor: 5.715

Review 4.  SOX9 Stem-Cell Factor: Clinical and Functional Relevance in Cancer.

Authors:  Maribel Aguilar-Medina; Mariana Avendaño-Félix; Erik Lizárraga-Verdugo; Mercedes Bermúdez; José Geovanni Romero-Quintana; Rosalío Ramos-Payan; Erika Ruíz-García; César López-Camarillo
Journal:  J Oncol       Date:  2019-04-01       Impact factor: 4.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.